RecruitingOBSERVATIONAL

European Registry on the Management of Helicobacter Pylori Infection

This study is creating a European-wide collection of information on how doctors manage H. pylori infection. Many different treatments exist, and they don't always work because bacteria can become resistant. This registry will look at what treatments doctors are currently using, how effective they are, and if they follow existing guidelines. By continually checking these practices, researchers hope to find the best and most cost-effective ways to treat H. pylori. This could lead to fewer re-treatments, accurate diagnoses, and a reduced risk of serious problems like stomach ulcers or even stomach cancer for patients across Europe.

At a glance

Status

Recruiting

Sponsor

Javier P. Gisbert

Enrolment target

10,000

Start

01 Jun 2013

Estimated completion

01 Dec 2034

H. Pylori Infection

What is this study about?

Imagine a common stomach germ called H. pylori that can cause problems like indigestion, stomach ulcers, and even, in some cases, stomach cancer. Doctors have different ways of treating this infection, but sometimes the treatments don't work as well as they should, often because the germ becomes resistant to medicines. Because of these challenges, it's important to keep learning and improving how we treat H. pylori.

This study is like a large survey for doctors across Europe. It's not testing new medicines or treatments. Instead, doctors are simply sharing details about their everyday practice – specifically, how they diagnose and treat patients with H. pylori. By collecting this information from many doctors over a long period, researchers can see what's happening in the real world. They want to understand which treatments are most often used, how well they work, and if doctors are following the latest advice and guidelines.

The main goal is to build a clear picture of current H. pylori treatment across Europe. This information will help experts understand if patients are getting the most effective care and if all countries have access to the best diagnostic tools and medicines. Ultimately, this will help update and create better guidelines for doctors, leading to more successful treatments, fewer repeat treatments, and a lower risk of serious health issues for patients with H. pylori infection.

Key takeaways

A major European study is observing how doctors treat H. pylori infection.
It aims to improve treatments and reduce re-treatments for this common stomach germ.
Data from real-world patients' routine care will be collected by doctors.
The study helps develop better guidelines to prevent problems like ulcers and stomach cancer.
Patients are not directly involved; their doctors provide anonymised information.

Who may be eligible?

This study is not looking for new patients to try out a treatment. Instead, it's gathering information from doctors about their existing patients who are being treated for H. pylori infection.

To be included in the information collected for this study, a patient must be an adult (18 years or older) and have been diagnosed with H. pylori infection. The study collects information on both male and female patients.

It's important to remember that you would not be directly participating in this study. Your doctor would be contributing information about your treatment if you meet these general criteria.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you 18 years old or older?
Have you been diagnosed with H. pylori infection?
Are you receiving treatment for H. pylori from a doctor in Europe?

Answer every question to see your result.

What does participation involve?

As a patient, you would not be actively participating in this study or having any direct involvement. This study is collecting information from doctors who are already treating patients with H. pylori in their regular clinics. Your doctor might contribute anonymous information about your anonymized data if you are an adult patient (18 years or older) diagnosed with H. pylori infection. This means your personal details won't be shared. There are no extra visits, assessments, medications, or follow-ups required from you for this study. It simply involves your doctor sharing details about your routine care for H. pylori.

Potential risks and benefits

There are no direct risks or benefits for patients related to this study, as patients are not directly taking part. The study simply collects anonymous data from doctors about routine care. The potential benefit is for future patients: by understanding what treatments work best in different places, doctors can improve H. pylori care across Europe, potentially leading to more effective treatments and fewer complications. You always have the right to discuss with your doctor whether anonymised information about your treatment can be used for research purposes.

Locations (30)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.

Medical University Wien
Verified postcode
Vienna, Austria· Recruiting
CHU de Charleroi, Charleroi
Verified postcode
Charleroi, Belgium· Recruiting
Medical University of Sofia
Verified postcode
Sofia, Bulgaria· Recruiting
University Hospital Merkur
Verified postcode
Zagreb, Croatia· Recruiting
Charles University Faculty of Medicine
Verified postcode
Prague, Czechia· Recruiting
Køge University Hospital
Verified postcode
Køge, Denmark· Recruiting
University of Tartu
Verified postcode
Tartu, Estonia· Recruiting
Herttoniemi Hospital, Helsinki
Verified postcode
Helsinki, Finland· Recruiting
Hôpital Pellegrin
Verified postcode
Bordeaux, France· Recruiting
Medizin Uni Magdeburg
Verified postcode
Magdeburg, Germany· Recruiting
Gastroenterology Clinic, Henry Dunant Hospital
Verified postcode
Athens, Greece· Recruiting
Ferencváros Health Centre, Gaastroenterology
Verified postcode
Budapest, Hungary· Recruiting

Common questions

What is H. pylori?

H. pylori is a common type of bacteria that can live in your stomach lining and cause issues like indigestion, stomach ulcers, and in some cases, stomach cancer.

How will this study help patients?

By understanding exactly how doctors across Europe treat H. pylori and what works best, this study aims to create better guidelines. This means patients might get more effective treatment, reducing the need for repeat treatments and lowering the risk of serious health problems.

Am I going to be asked to do anything for this study?

No, as a patient, you won't be asked to do anything extra. This study involves doctors sharing information about the care they already provide to their patients with H. pylori.

Will my personal information be shared?

No, all information collected for the study is anonymised, meaning your personal details that could identify you will not be shared. The focus is on treatment patterns, not individual identities.

Are they testing new drugs in this study?

No, this study is not testing new drugs. It is observing and recording how existing and standard H. pylori treatments are used in real-world everyday practice across Europe.

How to find out more

Javier Pérez Gisbert, MD

javier.p.gisbert@gmail.com +34 913093911 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.